Evidence map›Paper›PMID 32776232›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

Histologic subtype classification of non-small cell lung cancer using PET/CT images.

Yong Han, Yuan Ma, Zhiyuan Wu, Feng Zhang, Deqiang Zheng, Xiangtong Liu, Lixin Tao, Zhigang Liang, Zhi Yang, Xia Li and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Diagnosis of Lung Diseases in the Artificial Intelligence Era.International journal of molecular sciences · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yong HanDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Yuan MaDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Zhiyuan WuDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Feng ZhangDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Deqiang ZhengDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Xiangtong LiuDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Lixin TaoDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
Zhigang LiangDepartment of Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Zhi YangKey Laboratory of Carcinogenesis and Translational Research, Department of Nuclear Medicine, Peking University Cancer Hospital, Beijing, China.
Xia LiDepartment of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia.
Jian HuangSchool of Mathematical Sciences, University College Cork, Cork, Ireland.
Xiuhua GuoDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China. statguo@ccmu.edu.cn.

Funding

Beijing Municipal Commission of Education KZ201810025031National Natural Science Foundation of China 81703318National Natural Science Foundation of China 81773542
6 · The paper itself

Abstract

purposesTo evaluate the capability of PET/CT images for differentiating the histologic subtypes of non-small cell lung cancer (NSCLC) and to identify the optimal model from radiomics-based machine learning/deep learning algorithms.

methodsIn this study, 867 patients with adenocarcinoma (ADC) and 552 patients with squamous cell carcinoma (SCC) were retrospectively analysed. A stratified random sample of 283 patients (20%) was used as the testing set (173 ADC and 110 SCC); the remaining data were used as the training set. A total of 688 features were extracted from each outlined tumour region. Ten feature selection techniques, ten machine learning (ML) models and the VGG16 deep learning (DL) algorithm were evaluated to construct an optimal classification model for the differential diagnosis of ADC and SCC. Tenfold cross-validation and grid search technique were employed to evaluate and optimize the model hyperparameters on the training dataset. The area under the receiver operating characteristic curve (AUROC), accuracy, precision, sensitivity and specificity was used to evaluate the performance of the models on the test dataset.

resultsFifty top-ranked subset features were selected by each feature selection technique for classification. The linear discriminant analysis (LDA) (AUROC, 0.863; accuracy, 0.794) and support vector machine (SVM) (AUROC, 0.863; accuracy, 0.792) classifiers, both of which coupled with the ℓ

conclusionEmploying radiomic machine learning/deep learning algorithms could help radiologists to differentiate the histologic subtypes of NSCLC via PET/CT images.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansPositron Emission Tomography Computed TomographyRetrospective StudiesTomography, X-Ray ComputedHistologic subtypeMachine learningNon-small cell lung cancerPositron emission tomographyRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.